Despite the low mutational load and the immune milieu limiting the activity of immunotherapy in pancreatic cancer, MSI pancreatic tumors exhibit a higher infiltration of CD8 + T cells and higher PD-1 and PD-L1 expression compared to the microsatellite stable ones (Ghidini et al. 2021). This evidence concerns the gene CD8A and familial pancreatic carcinoma.